Very Severe Spinal Muscular Atrophy (Type 0): A Report of Three Cases by BARZEGAR, Mohammad et al.
51Iran J Child Neurology   Vol4 No2 Sep  2010
1. Professor of Pediatric 
Neurology, Pediatric Health 
Research Center, Tabriz University 
of Medical Sciences, Tabriz, Iran
2. Pediatrician, Faculty of 
Medicine, Tabriz University of 
Medical Sciences, Children 
Hospital, Tabriz, Iran 
3.Associate professor of 
Molecular-Medical Genetics, 




Children Hospital, Tabriz, Iran 




We describe three patients with very severe Spinal Muscular Atrophy (SMA) 
presented with reduced fetal movement in utero, profound hypotonia, severe 
weakness and respiratory insufficiency at birth. In all infants, electrodiagnostic 
studies were compatible with a neurogenic pattern. In genetic studies, all cases 
had homozygous deletions of exons 7 and 8 of Survival Motor Neuron (SMN) 
and exon 5 of Neuronal Apoptosis Inhibitory Protein (NAIP) gene. SMA should 
be considered in the differential diagnosis of reduced fetal movement and 
respiratory insufficiency at birth.
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Introduction
Spinal Muscular Atrophy (SMA) is an autosomal recessive disease characterized 
by degeneration of anterior horn cells of the spinal cord leading to progressive 
symmetrical weakness and atrophy of the proximal muscles (1). Clinically affected 
patients are classified into three or four groups according to the age of onset and 
progression of weakness. Children with type I SMA are the most severely affected 
ones and they usually have symptoms before 6 months of age. These patients are 
unable to sit and usually die within 1-2 years as a result of respiratory insufficiency. 
Type II patients have a milder presentation and survive into adolescence but they 
are unable to stand without support. Type III SMA is the mildest form (1). These 
three types are allelic and the majority are caused by homozygous deletions of the 
Survival Motor Neuron (SMN) gene localized on chromosome region 5q13 (2). In 
addition to these classical SMA types, unusual SMA variants have been described 
(3-5). Dubowitz described a new form of SMA called type 0 with intrauterine onset, 
leading to profound hypotonia, facial weakness, a progressive and early fatal course 
and death within the first 3 months (6). These infants present with asphyxia or 
severe respiratory distress in the neonatal period as a result of muscular weakness 
and usually need immediate intubation and artificial ventilation (6-9). This case 
study describes three patients with neonatal onset SMA. The patients presented with 
particularly severe forms of SMA with profound weakness and unusually severe 
respiratory distress at birth and all of them were ventilator dependent until death. 
                                                                                                                                        
Case report                                                                                                       
Case 1: This male infant was the third child born to consanguineous parents. The 
first child died of pneumonia at the age of 6 months. The second child was a 
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healthy baby. During pregnancy, fetal movements 
were absent from 32 weeks of gestation. There was 
no polyhydraminous. He was born at term with a birth 
weight of 3.3 Kg. The Apgar score was 8-9. There were 
no spontaneous respiratory movements and he was 
immediately intubated and ventilated artificially. He was 
referred to NICU on suspicion of respiratory distress 
syndrome. He was hypotonic with absent neonatal 
reflexes. On the 4th day of admission, he was examined 
by a pediatric neurologist. On this visit, he was ventilator 
dependent, alert and responsive to tactile stimuli; he 
opened his eyes in response to painful stimuli and had 
a weak cry. Deep tendon reflexes (DTRs) were absent. 
Electrodiagnostic studies showed a neurogenic pattern 
supporting the diagnosis of SMA. Molecular genetic 
analysis revealed the homozygous absence of exons 7 and 
8 of the Survival Motor Neuron (SMN) gene. Analysis 
of exon 5 of the NAIP gene detected a homozygous 
deletion. The baby died immediately after mechanical 
ventilation was discontinued at the request of his parents 
on the 25th day of life. Subsequent pregnancy resulted in a 
healthy baby.                                                                  
Case 2: This male infant was the first child born to 
unrelated parents. The pregnancy was unremarkable but 
the mother felt that fetal movements were reduced from 
34 weeks of gestation. He was born by spontaneous 
vaginal delivery at 38 weeks of gestation, weighing 2.95 
kg. He did not make any respiratory efforts, requiring 
intubation and mechanical ventilation at birth. Serum 
creatine kinase level was slightly elevated and tensilon 
test was normal. He had a bright normal expression 
with few spontaneous movements, a weak cry and 
absent DTRs. His molecular genetic analysis and 
electrodiagnostic studies were similar to case 1. He died 
38 days after admission when respiratory support was 
withdrawn at the request of the parents. The mother’s 
next pregnancy was terminated because genetic studies 
of the fetus in the 10th week of gestation were compatible 
with SMA.                                                   
Case 3: This female baby was the first child of a 23-
year-old healthy mother with an uneventful pregnancy. 
She was born by elective cesarean section at 39 weeks of 
gestation weighing 3.2 kg. She presented with asphyxia 
at birth and needed resuscitation and intubation and 
ventilator support. The baby was referred to NICU on 
suspicion of hypoxic ischemic encephalopathy (HIE). 
Brain sonography and CT scan were not remarkable. 
She was noted to be hypotonic with absent DTRs and 
spontaneous movements of the limbs. She had a bell 
shaped chest and tongue fasciculation and opened her 
eyes in response to painful stimuli. Her genetic analysis 
and electrodinagnostic studies were similar to case 1. On 
the 23th day of life, ventilatory support was electively 
withdrawn at the request of the parents.                       
Discussion
Although a substantial proportion of severe SMA (type 
1) patients may have a prenatal onset, spinal muscular 
atrophy is rarely symptomatic in the first few days after 
birth and when there is an early onset, it has a lethal 
course with respiratory problems and lifelong need to 
mechanical respiratory support (10).  MacLeod MJ et al. 
reported five cases of neonatal onset SMA with a history 
of diminished fetal movements in utero, presenting 
with asphyxia or severe weakness at birth. Three of 
their patients needed resuscitation and intubation and 
ventilatory support. Exons 7 and 8 of SMN gene were 
absent in all cases and four of the patients had deletions 
in NAIP gene (7). Two out of our three cases had reduced 
fetal movements and all of them had absent copies of 
exons 7 and 8 of the SMN gene and exon 5 of the NAIP 
gene.
Devriendt K et al reported a neonate who presented 
with fetal hypokinesia and signs of SMA at birth with 
deletions of both exon 7 of the SMN gene and exon 5 
of the NAIP gene (11). They concluded that NAIP gene 
played a major role in modifying the severity of the 
phenotype. In all our patients, deletion of the exon 5 of 
the NAIP gene was noted.            
 Korinthenberg et al. documented three siblings who 
presented with asphyxia, generalized weakness, facial 
weakness and external ophthalmoplegia in the newborn 
period; they were found to be absent for the SMN gene 
(12). 
 Pavone P, et al reported a case of SMA with respiratory 
failure being ventilator dependent at birth. The diagnosis 
was made by genetic analysis (8).
To date, it is not known with certainty whether this 
subgroup represents a distinct entity or is merely the 
severe end of the classic SMA type 1. Dubowitz explains 
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that from a classification point of view, the more severe 
cases with prenatal onset and intrauterine death or with 
severe asphyxia at birth and early neonatal death fit 
into the category of "very severe" SMA (type 0) as an 
extension to previous severe SMA (type1) (6).               
Prenatal analysis of SMN gene is useful for prenatal 
diagnosis of SMA when a positive family history is 
present (12). However, none of our patients had a 
documented family history of SMA. The diagnostic 
criteria for SMA do not include antenatal presentation 
(14); however, there have been case reports of in utero 
onset SMA (10,15). 
Although hypoxia is the most common cause of reduced 
fetal movements, rarer causes should be considered if 
there is a significant family history.
The most severe type of SMA presents itself at birth or in 
the early days of life which may be difficult for primary 
care providers or pediatricians to diagnose. Proper 
diagnosis of this disorder needs a high index of suspicion 
and understanding of clinical signs and symptoms. 
SMA should be kept in mind in the differential diagnosis 
for unexplained severe generalized hypotonia and 
severe respiratory distress immediately after birth in the 
neonates, notably in patients with a bright expression 
and alert disposition. 
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